Loading...
XASX
IDX
Market cap605mUSD
Dec 05, Last price  
2.45AUD
1D
-0.81%
1Q
-15.52%
Jan 2017
105.88%
IPO
31.02%
Name

Integral Diagnostics Ltd

Chart & Performance

D1W1MN
XASX:IDX chart
P/E
195.13
P/S
1.45
EPS
0.01
Div Yield, %
2.37%
Shrs. gr., 5y
9.02%
Rev. gr., 5y
18.01%
Revenues
627m
+33.54%
3,230,0004,120,000151,213,000167,770,000179,732,000189,399,000232,393,000274,081,000348,808,000358,739,000440,099,000469,697,000627,215,000
Net income
5m
P
3,229,8393,423,6794,500,00011,388,00015,480,00015,079,00020,983,00023,033,00031,268,00014,603,00025,040,000-60,699,0004,673,000
CFO
74m
+11.51%
3,739,8383,695,56017,112,00024,055,00022,730,00026,517,00033,923,00054,250,00069,572,00037,100,00071,418,00066,159,00073,774,000
Dividend
Aug 30, 20240.033 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.
IPO date
Oct 21, 2015
Employees
2,010
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT